GSK.L - GlaxoSmithKline plc

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in GBP. All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue30,186,00027,889,00023,923,00023,006,000
Cost of Revenue9,317,0008,986,0008,143,0007,323,000
Gross Profit20,869,00018,903,00015,780,00015,683,000
Operating Expenses
Research Development3,907,0003,456,0003,189,0003,450,000
Selling General and Administrative9,341,0008,690,0007,995,0008,246,000
Non Recurring----
Others-326,0001,292,000-269,000-6,000
Total Operating Expenses22,239,00022,424,00019,058,00019,013,000
Operating Income or Loss7,947,0005,465,0004,865,0003,993,000
Income from Continuing Operations
Total Other Income/Expenses Net-4,422,000-3,526,0005,661,000-1,025,000
Earnings Before Interest and Taxes7,947,0005,465,0004,865,0003,993,000
Interest Expense-722,000-701,000-719,000-683,000
Income Before Tax3,525,0001,939,00010,526,0002,968,000
Income Tax Expense1,356,000877,0002,154,000137,000
Minority Interest3,557,0003,839,0003,764,000673,000
Net Income From Continuing Ops2,169,0001,062,0008,372,0002,831,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income1,532,000912,0008,422,0002,756,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares1,532,000912,0008,422,0002,756,000